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Abstract Objectives: (1)To describe
the evolution of pulmonary capillary
pressure (Pcap) and of the pressure
drop across the pulmonary venous
bed from early to established acute
respiratory distress syndrome
(ARDS), (2) to assess Pcap under
different levels of positive end-expi-
ratory pressure (PEEP) and (3) to
compare the visual method and a
mathematical model to determine
Pcap. Design: Prospective, interven-
tion study. Setting: Intensive care
unit in a teaching institution. 
Patients: Nine ARDS patients, ac-
cording to the ARDS Consensus
Conference criteria. Interventions:
Pulmonary arterial pressures were
measured during routine respiratory
mechanics measurements throughout
ARDS. Four PEEP levels (6, 9, 12
and 15 cmH2O) were studied. 
Measurements and results: Pulmona-
ry artery occlusions were made in
triplicate at each PEEP level. Pcap
was determined for every occlusion
trace by three observers (visual
method) and a mathematical model.
Diastolic pulmonary artery pressure
(PAPd) and pulmonary artery occlu-
sion pressure (PAOP) were mea-
sured. The visually determined Pcap
showed a bias of 2.5±2.1 mmHg as
compared to the mathematical esti-
mation. PAPd, Pcap and PAOP tend-
ed to decrease from early to late
ARDS (p=0.128, 0.265, 0.121).
Pcap−PAOP (6.3±2.7 mmHg) did
not change throughout ARDS. High-
er PEEP levels were associated with
increased PAPd, Pcap and PAOP, as
well as with larger Pcap−PAOP
throughout ARDS. Conclusions:
Pulmonary capillary pressure cannot
be predicted from PAOP during early
and established ARDS. The high
variability in Pcap−PAOP increases
the risk for underestimation of filtra-
tion pressures and consequently the
risk for lung edema. Pcap can be es-
timated at the bedside by either the
visual or mathematical methods.
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Pulmonary capillary pressures during 
the acute respiratory distress syndrome
Introduction
Pulmonary capillary pressure (Pcap) cannot be measured
directly. Indirect methods seek to assess the pressure in
the sites where fluid leakage occurs [1]. Since Pcap is a
major determinant of fluid leakage, its importance is em-
phasized in the presence of increased permeability. In
ARDS, the gradient between Pcap and pulmonary artery
occlusion pressure (PAOP) (Pcap−PAOP) [2, 3, 4], as
well as capillary permeability [5] are increased. Evi-
dence exists that reduction of Pcap may improve lung
edema in the acute respiratory distress syndrome
(ARDS) [6, 7]. Although it is physiologically obvious
that PAOP is not a surrogate for Pcap in these circum-
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stances, Pcap is seldom assessed and PAOP is commonly
used to guide fluid management in ARDS. The protec-
tive approach to ventilation in ARDS advocates high
positive end-expiratory pressure (PEEP) levels and low
tidal volumes [8]. The effect of PEEP on Pcap and on
Pcap−PAOP remains unsettled. Since Pcap−PAOP is not
constant, hydrostatic pressure in the capillaries may be
grossly underestimated in the clinical setting.
We hypothesized that, in ARDS, Pcap−PAOP varies
over time and with PEEP level. We evaluated the evolu-
tion of Pcap and Pcap−PAOP from early to established
ARDS. In addition, we assessed the effect of PEEP on
Pcap and Pcap−PAOP. Pcap was determined using two
different methods. The reproducibility and between-
method variability of computed Pcap were evaluated.
Methods
Patients
Nine ARDS patients [9] were studied. Measurements
were made during acute ARDS (1–3 days after diagno-
sis), and repeated later (5–9 days after diagnosis), in six
patients. The study was approved by the Ethics Commit-
tee. The need for informed consent was waived since the
measurements required no additional instrumentation
and the assessment of Pcap was performed in conjunc-
tion with routine measurements of respiratory mechanics
[10]. Patients were intubated and ventilated under con-
trolled mode (Servo 900, Siemens-Elema, Sweden). All
patients had a pulmonary arterial catheter in place for
clinical purposes. Initial ventilator settings were deter-
mined by the attending physician (setVt, PEEPset). 
Demographic and clinical data [11] are presented in Ta-
ble 1.
Material
A heated pneumotachometer (Fleisch No2, Switzerland)
and two differential pressure transducers (Validyne,
MP45, ±2.0 and ±100.0 cmH2O; CA) were used for flow
and airway opening pressure measurements. Volume was
obtained by digital integration of the flow signal. 
Systemic and pulmonary artery pressures (SAP, PAP)
and central venous pressure (CVP) were obtained from a
patient monitor (AS3, Datex-Ohmeda, Finland). A phys-
iologic recording system (Direc, Raytech Instruments,
Canada) was used.
Protocol
Four PEEP levels (6, 9, 12 and 15 cmH2O) were used for
the assessment of respiratory mechanics and, at each
PEEP level, three tidal volumes (Vt) were used (setVt, a
20% higher Vt and a 20% lower Vt). Pcap measurements
were made only at setVt, by occluding the pulmonary ar-
tery in triplicate for a minimum of 6 s during an end-
expiratory pause. Static pressures were measured and
static compliance of the respiratory system calculated at
each ventilator setting by the occlusion method [12].
Analysis
Three intensive care specialists estimated Pcap using the
visual inspection method [13] (Fig. 1A). This method
has been validated and used experimentally and clinical-
ly [1, 2, 13]. The mathematical method chosen [14, 15]
has been validated against the double occlusion method
[1, 15]. We superimposed one non-occluded pulmonary
artery pressure curve to the occluded curve and defined
Table 1 Demographic and clinical data of the patients
Patient Age Diagnosis Outcome Day after ARDS PEEPset Static Murray
(no./sex) (year) diagnosis (cmH2O) compliance [11](ml/cmH2O)
1/M 28 Multiple trauma with thoracic Survived 1 10 67 2.75
and pulmonary contusion 7 8 41 2.5
2/M 37 Wegener’s granulomatosis Died 1 12 33 3.5
3/F 47 Pneumonia Survived 1 10 56 2.5
9 10 33 2.5
4/M 36 Pneumonia Survived 1 10 35 3.25
8 7 32 2.75
5/M 17 Pneumonia Survived 3 10 58 2.5
5 8 61 1.5
6/M 42 Acute hemorrhagic pancreatitis Died 3 6 38 3
7 6 38 3
7/F 70 Perforated duodenal ulcer; septic shock Survived 1 8 30 2.75
8/M 49 Pneumonia; septicemia Survived 1 6 30 2.75
6 6 30 3
9/M 22 Acute pancreatitis Survived 3 6 24 3
M male, F female, PEEPset positive end-expiratory pressure setting
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the moment of occlusion as the moment when the oc-
cluded pressure deviated below the non-occluded tracing
[16] (Fig. 1B). We fitted an exponential curve to the
pressure signal at two different time periods after occlu-
sion, 0.3–2.0 s as proposed by Hakim [15] (Fig. 1B) and
0.5–2.0 s. As extrapolation to time zero was shown to
overestimate Pcap [17], we used extrapolation to 0.2 s
after occlusion for the fitting period comprised between
0.3 and 2 s. This value approximates the most accurate
extrapolation time point (152 ms after occlusion) from
mono-exponential fitting [18]. An arbitrary extrapolation
to 0.3 s was used with the fitting from 0.5 to 2 s. The
mean PAP during the sixth second after occlusion was
used as PAOP. The pressure drop across the pulmonary
venous bed (Pcap−PAOP) was expressed as a fraction of
the total pressure drop across the pulmonary vascular
tree (PAPd−PAOP): [(Pcap−PAOP)/(PAPd−PAOP)] [16].
Pcap values determined by the three observers were 
averaged. Values obtained from the occlusions carried
out in triplicate were averaged and used to evaluate the
pressure changes across the pulmonary vasculature.
Statistics
Inter-observer and intra-observer coefficient of variation
were respectively computed for Pcap estimated by the
three observers for the same occlusion and for the occlu-
sions carried out in triplicate. A Bland-Altman plot as-
sessed the differences between Pcap analysis methods
[19]. The between-method differences and effect of
PEEP were assessed by multiple analysis of variance for
repeated measures (SPSS for Windows). Values are pre-
sented as means ± SD. A probability value of 0.05 or
less was considered significant.
Results
Pulmonary artery occlusions were performed in triplicate
at 59 time points, n=176 (one missing value). Thirty
curves (17%) were excluded due to spontaneous respira-
tory efforts (n=18), underdamping of the pulmonary ar-
tery pressure curve (n=4) and start of the pulmonary ar-
tery occlusion before the expiratory pressure plateau
(n=8).
Pulmonary capillary pressure values are shown in 
Table 2. Differences between observers were small
Fig. 1  A Visual inspection
method for estimation of pul-
monary capillary pressure
(Pcap); B Mathematical meth-
od for the estimation of Pcap
Table 2 Pulmonary capillary pressure (Pcap; means ± SD)
Pcap (mmHg) Obs. mean No. Exp0.3–2 (0.2) No. Exp0.5–2 (0.3) No.
Acute ARDS PEEP6 17.4±4.9 20 14.6±4.3 20 13.4±3.7 20
PEEP9 18.6±4.1 21 14.6±3.8 21 14.0±3.4 21
PEEP12 19.5±4.3 22 16.9±3.9 22 15.6±3.6 22
PEEP15 19.2±4.5 21 16.5±3.6 21 15.1±3.5 21
Total 18.7±4.5 84 15.7±4.0 84 14.5±3.6 84
Late ARDS PEEP6 15.2±3.0 18 13.2±2.6 18 11.6±2.3 18
PEEP9 15.0±2.4 15 13.2±3.2 15 11.9±2.6 15
PEEP12 16.2±2.7 15 14.8±3.1 15 13.5±2.9 15
PEEP15 17.5±2.3 14 16.0±3.1 14 14.7±2.8 14
Total 15.9±2.7 62 14.2±3.1 62 12.8±2.8 62
Total 17.5±4.0 146 15.1±3.7 146 13.8±3.4 146
Obs mean mean values of Pcap estimated by the three observers
(visual method), Exp0.3–2 (0.2) exponential fitting from 0.3 to 2 s
after occlusion extrapolated to 0.2 s after occlusion, Exp0.5–2 (0.3)
exponential fitting from 0.5 to 2 s after occlusion extrapolated to
0.3 s after occlusion, ARDS acute respiratory distress syndrome,
PEEP positive end-expiratory pressure
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(0.3±1.7 mmHg; 95%CI 0.16 mmHg) but consistent
(p=0.022). Mathematical estimations also showed small
(1.2±0.9 mmHg; 95%CI 0.14 mmHg), consistent differ-
ences (p<0.001). The exponential fitting from 0.5 to 2 s
after occlusion did not help to avoid artifacts as com-
pared to the model including a longer fitting. Only the
latter was used for further analysis. The visual approach
showed a bias of 2.5±2.1 mmHg as compared to the
mathematical method (Fig. 2). Intra-observer coefficient
of variation for the visual method ranged from 4.2±3.2%
to 6.3±5.4% and was 5.0±4.6% for the mathematical
model. Inter-observer variability was 5.6±4.1%.
Hemodynamic data are presented in Table 3. PAPd,
Pcap and PAOP tended to decrease towards late ARDS
(p=0.128, 0.265, 0.121) (Fig. 3). Pcap−PAOP did not
change throughout ARDS (7.7±2.7 vs 7.6±2.9 mmHg—
visual method; 4.7±2.4 vs 5.8±2.4 mmHg—mathemati-
cal method). PAPd, Pcap, PAOP and Pcap−PAOP in-
creased with PEEP throughout ARDS (Fig. 3). (Pcap−
PAOP)/(PAPd−PAOP) tended to increase during estab-
lished ARDS (p=0.085) and with PEEP (p=0.101)
(PEEP-phase of ARDS interaction: p=0.029) (Fig. 3).
Discussion
We found that: (1) PAPd, Pcap and PAOP decreased
from acute to established ARDS, while Pcap−PAOP re-
mained unchanged, (2) Pcap and Pcap−PAOP increased
with PEEP throughout ARDS and (3) Pcap can be esti-
mated at the bedside by either the visual or the mathe-
matical method.
Fig. 2 Bland-Altman plot com-
paring mean pulmonary capil-
lary pressure (Pcap) obtained
by the visual method to Pcap
values obtained by the mathe-
matical method. Agreement 
(r2) between methods was 0.74
Table 3 Hemodynamic data of the patients
Patient Day after ARDS CO PAOPa PAPd-PAOPa Visual Pcapa Math. Pcapa PVR VenR/PVR
(No./sex) diagnosis (l/min) (mmHg) (mmHg) (mmHg) (mmHg) (dyne . sec/cm5)
1/M 1 12.5 7.7 13.3 14.6 10.8 84.72 0.23
7 9.9 7 13 15.7 12.1 104.70 0.39
2/M 1 8.4 15 15.3 26.7 22.2 145.45 0.47
3/F 1 3.2 –b –b –b –b –b –b
9 3.9 6.7 10.3 15 11 211.79 0.42
4/M 1 12.5 10.7 11.6 19.2 12.9 74.33 0.19
8 7.1 6.3 16 20.3 15.3 179.82 0.56
5/M 3 12 11 7.3 15.1 13.3 48.75 0.31
5 9.8 9 5.3 12.4 10.1 43.16 0.22
6/M 3 11.9 7 7 12.1 10.3 47.15 0.47
7 8 10 8.3 16.4 16.4 83.12 0.77
7/F 1 4 10.3 17.5 21.8 18 350.05 0.46
8/M 1 7.2 14 7 19 18.8 77.52 0.68
6 6.5 6 6 11.1 11 73.53 0.84
9/M 3 8.4 14.3 9.7 20.9 17.3 91.91 0.31
M male, F female, ARDS acute respiratory distress syndrome, CO
cardiac output, measured prior to positive end-expiratory pressure
(PEEP) manipulations, PAOP pulmonary artery occlusion pres-
sure, PAPd diastolic pulmonary artery pressure, Pcap capillary
pulmonary pressure, PVR pulmonary vascular resistance [(PAPd-
PAOP)/CO], VenR/PVR venous pulmonary vascular resistance /
total pulmonary vascular resistance
a Values obtained during the PEEP level closest to PEEPset




Direct measurement of Pcap in patients is not possible,
but surrogate estimates can be obtained. Analysis of the
post-occlusion pulmonary artery pressure trace is based
on a model of pulmonary vasculature which does not in-
clude the resistive component of pulmonary capillaries.
Some degree of Pcap overestimation can therefore be ex-
pected.
The slow inflation of the Swan-Ganz balloon decreas-
es the initial slope of the occlusion curve and the separa-
tion between the instantaneous drop and the slower
phase is not always self-evident [15]. This may explain
the higher values computed by the visual method (which
uses the initial slope) as compared to the mathematical
method (which uses the unaffected slower phase)
(2.5±2.1 mmHg). Despite this, the two techniques had
similar variability. Comparable between-method differ-
ences and variability have been reported previously [3,
4, 13]. Our data comprise traces with the pulmonary ar-
tery occlusion happening in every phase of the heart cy-
cle. Inaccuracies may originate here, both due to the ac-
centuated initial “fast component” occurring during sys-
tole [15] and due to a less accurate identification of the
time of occlusion during diastole [18]. However, Pcap
estimations were obtained in triplicate at each PEEP lev-
el and averaged for clinical analysis—a practice similar
to the measurement of cardiac output.
Clinical analysis
To our knowledge, no data exist on the evolution of Pcap
and Pcap−PAOP with PEEP and throughout ARDS. Our
results show large, highly variable Pcap−PAOP values
throughout ARDS. (Pcap−PAOP)/(PAPd−PAOP) tended
to rise during established ARDS (Fig. 3) despite de-
creased cardiac output. This rise may be due to a larger
decrease of PAP and PAOP as compared to Pcap from
the acute to the late phases of ARDS, possibly caused by
a “dry-lung” approach to fluid management in our unit.
PAP, Pcap, PAOP and pulmonary venous resistances
have been shown to increase with PEEP [20, 21]. Our
data suggest a similar behavior of Pcap and Pcap−PAOP
with increasing PEEP during ARDS (Fig. 3 ). Unfortu-
nately we have no data on the effect of PEEP on blood
flow. If anything, PEEP would be expected to decrease
cardiac output and thereby attenuate an increase in
Pcap−PAOP. Since the number of patients studied was
small, especially in the arbitrarily defined late phase,
conclusions on the time course of Pcap throughout
ARDS cannot be drawn. Despite high inter-individual
variability, our data demonstrates that high Pcap may be
present in established ARDS.
Assuming that elevated Pcap contributes to lung ede-
ma in ARDS, highly variable Pcap−PAOP in ARDS may
lead to underestimation of the risk for lung edema. This
and the variability of Pcap throughout ARDS should be
taken into consideration when manipulating filling pres-
sures. Both the visual and mathematical methods of esti-
mating Pcap are suitable for bedside use.
Fig. 3 Left Y axis (for both acute and late ARDS): Pulmonary ar-
tery occlusion pressure (PAOP; circles), pulmonary capillary pres-
sure (Pcap; visual method = filled triangles; mathematical method
= open triangles) and diastolic pulmonary artery pressure (PAPd;
squares). Right Y axis (for both acute and late ARDS): (symbols
connected by a dotted line) venous component of the pressure
drop across the pulmonary vasculature (Pcap−PAOP)/(PAPd−
PAOP)—(Pcap determined by the visual method = filled stars;
Pcap determined by the mathematical method = open stars) at dif-
ferent positive end-expiratory pressure (PEEP) levels during the
acute and late stage of acute respiratory distress syndrome (ARDS)
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